GSA Capital Partners’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-11,116
Closed -$281K 1592
2024
Q1
$281K Buy
+11,116
New +$281K 0.02% 1254
2023
Q4
Sell
-20,597
Closed -$1.04M 1459
2023
Q3
$1.04M Buy
+20,597
New +$1.04M 0.09% 373
2023
Q1
Sell
-5,106
Closed -$280K 1446
2022
Q4
$280K Buy
+5,106
New +$280K 0.03% 974